SHANGHAI ZHEYE BIOTECHNOLOGY CO LTD has a total of 11 patent applications. It decreased the IP activity by 71.0%. Its first patent ever was published in 2017. It filed its patents most often in China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ABBVIE BV, VIROCHEM PHARMA INC and NIPPON CHEMIPHAR CO.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Yuan Hao | 4 |
#2 | Zhang Lei | 4 |
#3 | Zhang Haidong | 3 |
#4 | Liu Jianyu | 3 |
Publication | Filing date | Title |
---|---|---|
CN111362922A | 2, 4-diaminopyrimidine derivatives and their use | |
CN111362928A | 2, 4-diaminopyrimidine derivatives | |
CN108341816A | A kind of selective depression kinases compound | |
CN108341837A | It is a kind of to inhibit kinases compound and its purposes medically | |
CN108341815A | A kind of inhibition kinases compound and application thereof | |
CN108264510A | A kind of selective depression kinases compound and application thereof |